Edmund G. Anderson - Publications

Affiliations: 
University of Illinois - Chicago, Chicago, IL, United States 

71 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
1997 Todorovic SM, Scroggs RS, Anderson EG. Cationic modulation of 5-HT2 and 5-HT3 receptors in rat sensory neurons: the role of K+, Ca2+ and Mg2+. Brain Research. 765: 291-300. PMID 9313902 DOI: 10.1016/S0006-8993(97)00574-X  1
1994 Borg C, Lim CT, Yeomans DC, Dieter JP, Komiotis D, Anderson EG, Le Breton GC. Purification of rat brain, rabbit aorta, and human platelet thromboxane A2/prostaglandin H2 receptors by immunoaffinity chromatography employing anti-peptide and anti-receptor antibodies. The Journal of Biological Chemistry. 269: 6109-16. PMID 8119956  1
1994 Roychowdhury S, Haas H, Anderson EG. 5-HT1A and 5-HT4 receptor colocalization on hippocampal pyramidal cells. Neuropharmacology. 33: 551-7. PMID 7984294 DOI: 10.1016/0028-3908(94)90086-8  1
1994 Scroggs RS, Todorovic SM, Anderson EG, Fox AP. Variation in IH, IIR, and ILEAK between acutely isolated adult rat dorsal root ganglion neurons of different size. Journal of Neurophysiology. 71: 271-9. PMID 7512627  1
1992 Todorovic S, Anderson EG. Serotonin preferentially hyperpolarizes capsaicin-sensitive C type sensory neurons by activating 5-HT1A receptors. Brain Research. 585: 212-8. PMID 1511304 DOI: 10.1016/0006-8993(92)91209-W  1
1990 Todorovic SM, Anderson EG. Pharmacological characterization of 5-hydroxytryptamine2 and 5-hydroxytryptamine3 receptors in rat dorsal root ganglion cells. The Journal of Pharmacology and Experimental Therapeutics. 254: 109-15. PMID 2366178  1
1990 Todorović S, Anderson EG. 5-HT2 and 5-HT3 receptors mediate two distinct depolarizing responses in rat dorsal root ganglion neurons. Brain Research. 511: 71-9. PMID 2331619 DOI: 10.1016/0006-8993(90)90226-2  1
1990 Scroggs RS, Anderson EG. 5-HT1 receptor agonists reduce the Ca+ component of sensory neuron action potentials. European Journal of Pharmacology. 178: 229-32. PMID 2328764 DOI: 10.1016/0014-2999(90)90479-P  1
1990 Glaum SR, Proudfit HK, Anderson EG. 5-HT3 receptors modulate spinal nociceptive reflexes. Brain Research. 510: 12-6. PMID 2322835 DOI: 10.1016/0006-8993(90)90721-M  1
1990 Grigg JJ, Anderson EG. Competitive and noncompetitive N-methyl-D-aspartate antagonists modify hypoxia-induced membrane potential changes and protect rat hippocampal slices from functional failure: a quantitative comparison. The Journal of Pharmacology and Experimental Therapeutics. 253: 130-5. PMID 1970359  1
1989 Grigg JJ, Anderson EG. Glucose and sulfonylureas modify different phases of the membrane potential change during hypoxia in rat hippocampal slices. Brain Research. 489: 302-10. PMID 2501003 DOI: 10.1016/0006-8993(89)90863-9  1
1989 Scroggs RS, Anderson EG. Serotonin modulates calcium-dependent plateau of action potentials recorded from bull frog A-type sensory neurons which is omega-conotoxin GVIA-sensitive, but dihydropyridine-insensitive. Brain Research. 485: 391-5. PMID 2470474 DOI: 10.1016/0006-8993(89)90583-0  1
1988 Glaum SR, Anderson EG. Identification of 5-HT3 binding sites in rat spinal cord synaptosomal membranes. European Journal of Pharmacology. 156: 287-90. PMID 3240771 DOI: 10.1016/0014-2999(88)90335-4  1
1988 Glaum SR, Proudfit HK, Anderson EG. Reversal of the antinociceptive effects of intrathecally administered serotonin in the rat by a selective 5-HT3 receptor antagonist. Neuroscience Letters. 95: 313-7. PMID 3226619 DOI: 10.1016/0304-3940(88)90677-5  1
1988 Marszalec W, Anderson EG. Three putative 5-HT1A agonists act as 5-HT antagonists in frog sensory neurons. European Journal of Pharmacology. 154: 325-8. PMID 2976672 DOI: 10.1016/0014-2999(88)90209-9  1
1988 Marszalec W, Scroggs RS, Anderson EG. Serotonin-induced reduction of the calcium-dependent plateau in frog dorsal root ganglion cells is blocked by serotonergic agents acting at 5-hydroxytryptamine1A sites. The Journal of Pharmacology and Experimental Therapeutics. 247: 399-404. PMID 2972829  1
1987 Buzsáki G, Haas HL, Anderson EG. Long-term potentiation induced by physiologically relevant stimulus patterns. Brain Research. 435: 331-3. PMID 3427460 DOI: 10.1016/0006-8993(87)91618-0  1
1986 Larson AA, Anderson EG. Action of hallucinogens on raphe-evoked dorsal root potentials (DRPs) in the cat. Pharmacology, Biochemistry, and Behavior. 24: 347-50. PMID 3952125 DOI: 10.1016/0091-3057(86)90364-3  1
1986 Holz GG, Shefner SA, Anderson EG. Serotonin decreases the duration of action potentials recorded from tetraethylammonium-treated bullfrog dorsal root ganglion cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 6: 620-6. PMID 3485707  1
1986 Morris RG, Anderson E, Lynch GS, Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature. 319: 774-6. PMID 2869411 DOI: 10.1038/319774a0  1
1985 Rabin AG, Anderson EG, Levy RA. Autotomy following limb denervation: effects of sparing selected afferents. Pain. 21: 117-28. PMID 4039052 DOI: 10.1016/0304-3959(85)90281-7  1
1985 Rabin AG, Anderson EG. Autotomy following limb denervation: effects of previous exposure to neurectomy. Pain. 21: 105-15. PMID 4039051 DOI: 10.1016/0304-3959(85)90280-5  1
1985 Holz GG, Shefner SA, Anderson EG. Serotonin depolarizes type A and C primary afferents: an intracellular study in bullfrog dorsal root ganglion. Brain Research. 327: 71-9. PMID 3872695 DOI: 10.1016/0006-8993(85)91500-8  1
1984 Holz GG, Anderson EG. The actions of serotonin on frog primary afferent terminals and cell bodies. Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology. 77: 13-21. PMID 6141866 DOI: 10.1016/0742-8413(84)90124-5  1
1983 Wessendorf MW, Anderson EG. Single unit studies of identified bulbospinal serotonergic units. Brain Research. 279: 93-103. PMID 6315185 DOI: 10.1016/0006-8993(83)90166-X  1
1981 Wessendorf MW, Proudfit HK, Anderson EG. The identification of serotonergic neurons in the nucleus raphe magnus by conduction velocity. Brain Research. 214: 168-73. PMID 7237156 DOI: 10.1016/0006-8993(81)90449-2  1
1981 Larson AA, Chinn C, Proudfit HK, Anderson EG. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei. The Journal of Pharmacology and Experimental Therapeutics. 217: 99-104. PMID 6110778  1
1981 Wessendorf MW, Anderson EG, Proudfit HK. Effects of iontophoretic application of acetylcholine (Ach) and norepinephrine (NE) to identified serotonergic (5-HT) and non-serotonergic neurons in the nucleus raphe magnus (NRM) Pharmacologist. 23: No. 102.  1
1980 Proudfit HK, Larson AA, Anderson EG. The role of GABA and serotonin in the mediation of raphe-evoked spinal cord dorsal root potentials. Brain Research. 195: 149-65. PMID 6249439 DOI: 10.1016/0006-8993(80)90873-2  1
1980 Goldstein BD, Hettasch JM, Anderson EG. Effects of harmaline on spinal reflex activity Pharmacologist. 22: 151.  1
1980 Anderson EG. Are there too many neurotransmitters? Trends in Pharmacological Sciences. 1: 246-247.  1
1979 Larson AA, Anderson EG. Changes in primary afferent depolarization after administration of gamma-acetylenic gamma aminobutyric acid (GAG), a gamma-aminobutyric acid (GABA) transaminase inhibitor. The Journal of Pharmacology and Experimental Therapeutics. 211: 326-30. PMID 501564  1
1978 Myslinski NR, Anderson EG. The effect of serotonin precursors on alpha- and gamma-motoneuron activity. The Journal of Pharmacology and Experimental Therapeutics. 204: 19-26. PMID 304098  1
1978 Larson AA, Anderson EG. Changes in dorsal root potentials after administration of RMI 71645, a GABA transaminase inhibitor Federation Proceedings. 37: No. 719.  1
1976 Repkin AH, Wolf P, Anderson EG. Non-GABA mediated primary afferent depolarization. Brain Research. 117: 147-52. PMID 990931 DOI: 10.1016/0006-8993(76)90565-5  1
1976 Lobatz MA, Proudfit HK, Anderson EG. Effects of noxious stimulation, iontophoretic morphine and norepinephrine on neurons in nucleus raphe magnus Pharmacologist. 18: No.546.  1
1975 Proudfit HK, Anderson EG. Morphine analgesia: blockade by raphe magnus lesions. Brain Research. 98: 612-18. PMID 1182544 DOI: 10.1016/0006-8993(75)90380-7  1
1975 Haas HL, Hosli L, Anderson EG, Wolf P. Action of histamine and metabolites on single neurones of the mammalian central nervous system | NEUROPSYCHOPHARMACOLOGY. PROCEEDINGS OF THE IX CONGRESS OF THE COLLEGIUM INTERNATIONALE NEUROPSYCHOPHARMACOLOGICUM, PARIS, 7-12 JULY, 1974 Excerpta Medica, Amsterdam. 589-596.  1
1975 Wolf P, Repkin AH, Anderson EG. Possible role of serotonin in a non GABA mediated depolarization of primary afferent terminals Federation Proceedings. 34: No.446.  1
1974 Bell JA, Anderson EG. Dissociation between amino-oxyacetic acid-induced depression of spinal reflexes and the rise in cord GABA levels. Neuropharmacology. 13: 885-94. PMID 4154420 DOI: 10.1016/0028-3908(74)90044-6  1
1974 Proudfit HK, Anderson EG. New long latency bulbospinal evoked potentials blocked by serotonin antagonists. Brain Research. 65: 542-6. PMID 4153414 DOI: 10.1016/0006-8993(74)90246-7  1
1974 Levy RA, Anderson EG. The role of gamma-aminobutyric acid as a mediator of positive dorsal root potentials. Brain Research. 76: 71-82. PMID 4152375 DOI: 10.1016/0006-8993(74)90514-9  1
1974 Proudfit HK, Anderson EG. Blockade of morphine analgesia by destruction of a bulbospinal serotonergic pathway Pharmacologist. 16: 073.  1
1974 Myslinski NR, Anderson EG. Control of alpha and gamma motoneurons by the bulbospinal serotonergic pathway Federation Proceedings. 33: No. 304.  1
1974 Repkin AH, Proudfit HK, Anderson EG. Primary afferent depolarization as a mechanism of morphine analgesia Pharmacologist. 16: 074.  1
1973 Proudfit HK, Anderson EG. Influence of serotonin antagonists on bulbospinal systems. Brain Research. 61: 331-41. PMID 4773165 DOI: 10.1016/0006-8993(73)90537-4  1
1973 Levy RA, Anderson EG. Bicuculline and picrotoxin blockade of positive dorsal root potentials. Nature: New Biology. 241: 156-8. PMID 4512621  1
1973 Taber CA, Anderson EG. Paradoxical blockade by p-chlorophenylalanine of 5-hydroxytryptophan facilitatory actions on spinal reflexes. The Journal of Pharmacology and Experimental Therapeutics. 187: 229-38. PMID 4356011  1
1973 Anderson EG, Haas HL, Hösli L. Comparison of effects of noradrenaline and histamine with cyclic AMP on brain stem neurones. Brain Research. 49: 471-5. PMID 4352735 DOI: 10.1016/0006-8993(73)90445-9  1
1973 Haas HL, Anderson EG, Hösli L. Histamine and metabolites: their effects and interactions with convulsants on brain stem neurones. Brain Research. 51: 269-78. PMID 4145193 DOI: 10.1016/0006-8993(73)90378-8  1
1973 Proudfit HK, Anderson EG. Blockade by serotonin antagonists of brain stem evoked potentials recorded fom spinal dorsal and ventral roots Federation Proceedings. 32: I.  1
1973 Repkin AH, Anderson EG. Bicuculline sensitive and bicuculline resistant primary afferent depolarization (PAD) Pharmacologist. 15: 41.  1
1972 Haas HL, Hösli L, Anderson EG. [Inhibition of brain-stem neurons by histamin and metabolites]. PflüGers Archiv : European Journal of Physiology. 332: Suppl 332:R86. PMID 5065870  1
1972 Levy RA, Anderson EG. The effect of the GABA antagonists bicuculline and picrotoxin on primary afferent terminal excitability. Brain Research. 43: 171-80. PMID 4340463 DOI: 10.1016/0006-8993(72)90282-X  1
1972 Bell JA, Anderson EG. The influence of semicarbazide-induced depletion of -aminobutyric acid on presynaptic inhibition. Brain Research. 43: 161-9. PMID 4340462 DOI: 10.1016/0006-8993(72)90281-8  1
1972 Anderson EG. Bulbospinal serotonin-containing neurons and motor control. Federation Proceedings. 31: 107-12. PMID 4333246  1
1971 Levy RA, Repkin AH, Anderson EG. The effect of bicuculline on primary afferent terminal excitability. Brain Research. 32: 261-5. PMID 4329653 DOI: 10.1016/0006-8993(71)90178-8  1
1970 Baker RG, Anderson EG. The effects of L-3,4-dihydroxyphenylalanine on spinal reflex activity. The Journal of Pharmacology and Experimental Therapeutics. 173: 212-23. PMID 5442299  1
1970 Baker RG, Anderson EG. The antagonism of the effects of L-3,4-dihydroxyphenylalanine of spinal reflexes by adrenergic blocking agents. The Journal of Pharmacology and Experimental Therapeutics. 173: 224-31. PMID 4392761  1
1969 Clineschmidt BV, Anderson EG. Lyasergic acid diethylamide: antagonism of supraspinal inhibition of spinal reflexes. Brain Research. 16: 296-300. PMID 5348860  1
1968 Shibuya T, Anderson EG. The influence of chronic cord transection on the effects of 5-hydroxytryptophan, l-tryptophan and pargyline on spinal neuronal activity. The Journal of Pharmacology and Experimental Therapeutics. 164: 185-90. PMID 5303400  1
1968 Banna NR, Anderson EG. The effects of 5-hydroxytryptamine antagonists on spinal neuronal activity. The Journal of Pharmacology and Experimental Therapeutics. 162: 319-25. PMID 5302116  1
1967 Anderson EG, Baker RG, Banna NR. The effects of monoamine oxidase inhibitors on spinal synaptic activity. The Journal of Pharmacology and Experimental Therapeutics. 158: 405-15. PMID 5299660  1
1966 Anderson EG, Baker R, Banna N. A comparison of the effects of some monoamine oxidase (MAO) inhibitors with 5-hydroxytryptophan (5-HTP) and dihydroxyphenylalanine (DOPA) on spinal synaptic activity. Proceedings of the Western Pharmacology Society. 9: 40-1. PMID 5958499  1
1963 ANDERSON EG, AMMANN A. The effects of monoamine oxidase inhibitors on neuromyal transmission. The Journal of Pharmacology and Experimental Therapeutics. 140: 179-82. PMID 14012843  1
1962 BONNYCASTLE DD, BONNYCASTLE MF, ANDERSON EG. The effect of a number of central depressant drugs upon brain 5-hydroxytryptamine levels in the rat. The Journal of Pharmacology and Experimental Therapeutics. 135: 17-20. PMID 13871074  1
1962 ANDERSON EG, MARKOWITZ SD, BONNYCASTLE DD. Brain 5-hydroxytryptamine and anticonvulsant activity. The Journal of Pharmacology and Experimental Therapeutics. 136: 179-82. PMID 13861220  1
1960 ANDERSON EG, BONNYCASTLE DD. A study of the central depressant action of pentobarbital, phenobarbital and diethyl ether in relationship to increases in brain 5-hy-droxytryptamine. The Journal of Pharmacology and Experimental Therapeutics. 130: 138-43. PMID 13683196  1
1956 ANDERSON EG, MAGEE DF. A study of the mechanism of the effect of dietary fat in decreasing thiopental sleeping time. The Journal of Pharmacology and Experimental Therapeutics. 117: 281-6. PMID 13332574  1
1955 MAGEE DF, ANDERSON EG. Changes in pancreatic enzymes brought about by alteration in the nature of the dietary protein. The American Journal of Physiology. 181: 79-82. PMID 14376575  1
1953 ANDERSON EG, MAGEE DF. Effect of feeding fat on duration of thiopental anesthesia. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 83: 110-1. PMID 13064191  1
Show low-probability matches.